Method for treating ocular pain

Details for Australian Patent Application No. 2001238313 (hide)

Owner Allergan, Inc.

Inventors Donello, John E; Stern, Michael E; Gil, Daniel W

Agent Davies Collison Cave

Pub. Number AU-B-2001238313

PCT Pub. Number WO01/60347

Priority 60/182,609 15.02.00 US

Filing date 15 February 2001

Wipo publication date 27 August 2001

Acceptance publication date 27 May 2004

International Classifications

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 031/00

A61P 027/02 Drugs for disorders of the senses

Event Publications

27 May 2004 Application Accepted

  Published as AU-B-2001238313

24 June 2004 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 27 May 2004. Address for service in Australia - Davies Collison Cave Level 10 10 Barrack Street Sydney NSW 2000

23 September 2004 Standard Patent Sealed

4 November 2004 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 27 May 2004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001238314-Spinal implant connection assembly

2001238312